BURLINGTON, Mass. & OXFORD, England--(BUSINESS WIRE)--Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced the topline results from an investigational clinical trial ...

Using an engineered common cold virus, UCLA researchers delivered a genetic payload to prostate cancer cells that allowed them, using positron emission tomography, to locate the diseased cells as they ...

A new multi-institutional study led by investigators at Duke University Medical Center indicates that a diagnostic scan may help localize recurrent prostate disease in men who have had surgical ...

The LOCATE trial was a prospective, U.S., multicenter, open-label study investigating the impact of 18 F-fluciclovine PET/CT imaging on patient management of biochemically recurrent prostate cancer ...

Using an engineered common cold virus, UCLA researchers delivered a genetic payload to prostate cancer cells that allowed them, using Positron Emission Tomography (PET), to locate the diseased cells ...

DURHAM, N.C. -- A new multi-institutional study led by investigators at Duke University Medical Center indicates that a diagnostic scan may help localize recurrent prostate disease in men who have had ...

Researchers at the University of California, Los Angeles (UCLA) have successfully used an engineered common cold virus to deliver a genetic payload to prostate cancer cells in mice, which enabled them ...

UCLA researchers are using PET scans to pinpoint and track cancer cells as they spread to the lymph nodes in mice, a method they believe has the potential to improve the way advanced prostate cancer ...